Day One Biopharmaceuticals Inc (DAWN)
13.77
-0.10
(-0.72%)
USD |
NASDAQ |
May 24, 16:00
13.76
-0.01
(-0.07%)
After-Hours: 20:00
Day One Biopharmaceuticals Shareholders Equity (Quarterly): 296.81M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 296.81M |
December 31, 2023 | 346.54M |
September 30, 2023 | 389.63M |
June 30, 2023 | 426.05M |
March 31, 2023 | 300.42M |
December 31, 2022 | 332.04M |
September 30, 2022 | 363.08M |
Date | Value |
---|---|
June 30, 2022 | 390.63M |
March 31, 2022 | 259.60M |
December 31, 2021 | 281.15M |
September 30, 2021 | 297.67M |
June 30, 2021 | 311.76M |
March 31, 2021 | -68.85M |
December 31, 2020 | -54.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-68.85M
Minimum
Mar 2021
426.05M
Maximum
Jun 2023
276.59M
Average
306.09M
Median
Shareholders Equity (Quarterly) Benchmarks
Revolution Medicines Inc | 1.725B |
Zentalis Pharmaceuticals Inc | 458.77M |
Perspective Therapeutics Inc | 229.89M |
Electromed Inc | 42.54M |
Xtant Medical Holdings Inc | 47.68M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 326.64M |
Total Liabilities (Quarterly) | 29.84M |